Rapid Micro Biosystems, Inc. financial data

Symbol
RPID on Nasdaq
Location
25 Hartwell Avenue, Lexington, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 428 % -30.8%
Quick Ratio 126 % +1.8%
Debt-to-equity 43.3 % +91.4%
Return On Equity -73.9 % -53.8%
Return On Assets -51.6 % -31.6%
Operating Margin -149 % +25%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 28.2M USD 0%
Weighted Average Number of Shares Outstanding, Basic 45M shares +2.95%
Weighted Average Number of Shares Outstanding, Diluted 45M shares +2.95%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 30.5M USD +16.6%
Research and Development Expense 13.8M USD -5.02%
Selling and Marketing Expense 11.7M USD -12.7%
General and Administrative Expense 22.2M USD -1.85%
Costs and Expenses 75.9M USD -2.71%
Operating Income (Loss) -45.4M USD +12.5%
Nonoperating Income (Expense) 1.14M USD -67.8%
Income Tax Expense (Benefit) 17K USD -56.4%
Net Income (Loss) Attributable to Parent -44.3M USD +8.48%
Earnings Per Share, Basic -1 USD/shares +9.82%
Earnings Per Share, Diluted -1 USD/shares +9.82%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.9M USD -14.1%
Accounts Receivable, after Allowance for Credit Loss, Current 5.43M USD +45.2%
Inventory, Net 21.1M USD -0.87%
Other Assets, Current 621K USD -17.3%
Assets, Current 70M USD -20.5%
Property, Plant and Equipment, Net 9.58M USD -17.1%
Operating Lease, Right-of-Use Asset 4.24M USD -19.2%
Other Assets, Noncurrent 211K USD -67.1%
Assets 84.4M USD -20.3%
Accounts Payable, Current 3.59M USD +54.2%
Employee-related Liabilities, Current 4.38M USD -5.52%
Accrued Liabilities, Current 6.61M USD -6.11%
Contract with Customer, Liability, Current 5.07M USD -5.41%
Liabilities, Current 16.5M USD +3.94%
Contract with Customer, Liability, Noncurrent 0 USD
Operating Lease, Liability, Noncurrent 3.86M USD -24.1%
Other Liabilities, Noncurrent 340K USD +17.6%
Liabilities 40.1M USD +86.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 12K USD -85.5%
Retained Earnings (Accumulated Deficit) -510M USD -9.51%
Stockholders' Equity Attributable to Parent 44.3M USD -47.5%
Liabilities and Equity 84.4M USD -20.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.07M USD +41.6%
Net Cash Provided by (Used in) Financing Activities 379K USD +140%
Net Cash Provided by (Used in) Investing Activities 10.7M USD -21%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.2M USD -13.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12K USD +33.3%
Deferred Tax Assets, Valuation Allowance 82.6M USD +16.1%
Deferred Tax Assets, Gross 84.1M USD +15.4%
Operating Lease, Liability 5.08M USD -18.4%
Payments to Acquire Property, Plant, and Equipment 319K USD -45.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -44.4M USD +7.31%
Lessee, Operating Lease, Liability, to be Paid 5.45M USD -20%
Property, Plant and Equipment, Gross 28.2M USD +0.76%
Operating Lease, Liability, Current 1.23M USD +6.79%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.44M USD +2.43%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.4M USD +2.41%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 371K USD -36.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.47M USD +2.37%
Deferred Tax Assets, Operating Loss Carryforwards 65.3M USD +17.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 804K USD -45.3%
Operating Lease, Payments 340K USD +2.72%
Additional Paid in Capital 554M USD +0.78%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 847K USD +5.09%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 4.1M USD -2.66%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%